Lifitegrast
Lifitegrast is listed in the FDA National Drug Code directory with 15 NDC codes, marketed under brand names including Xiidra, Lifitegrast. Available dosage forms: solution/ drops, powder, for solution.
Drug Details
- Generic Name
- Lifitegrast
- Brand Names
- Xiidra, Lifitegrast
- Application Number
- NDA208073
- Sponsor
- Bausch & Lomb Incorporated
- NDC Codes
- 15
- Dosage Forms
- SOLUTION/ DROPS, POWDER, FOR SOLUTION
- Routes
- OPHTHALMIC
- Active Ingredients
- LIFITEGRAST
Indications and Usage
1 INDICATIONS AND USAGE Lifitegrast ophthalmic solution 5% is indicated for the treatment of the signs and symptoms of dry eye disease (DED). Lifitegrast ophthalmic solution 5% is a lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the treatment of the signs and symptoms of dry eye disease (DED).